Sign inGet started

Livingston Philip O.

Insider CIK 1612050 · MBVX Chief Science Officer, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
MBVX MABVAX THERAPEUTICS HOLDIN A Award deriv2018-02-212018-02-2335,000— $035,000SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN S Sale2018-01-122018-01-163,571$0.96 $3.4K256,554SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN S Sale2018-01-112018-01-1612,301$0.98 $12.1K260,125SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN S Sale2018-01-102018-01-1621,155$0.96 $20.3K272,426SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN M Exercise deriv2018-01-082018-01-16100,000— $00SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN M Exercise2018-01-082018-01-16100,000— $0293,581SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN A Award deriv2017-10-022017-10-0475,790— $075,790SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN A Award deriv2017-09-152017-09-1824,210— $024,210SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN A Award deriv2017-05-192017-05-2350,000$2.00 $100.0K50,000SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN A Award deriv2017-01-012017-01-03700$3.38 $2.4K700SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN A Award deriv2016-08-292016-08-30700$5.00 $3.5K700SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN A Award2015-04-042015-04-071,000,000— $01,307,396SEC↗